Issue 3/2019
Content (23 Articles)
Surgical and radiosurgical treatment strategies for Cushing’s disease
Adomas Bunevicius, Edward R. Laws, Mary Lee Vance, Sherry Iuliano, Jason Sheehan
Radiation chronotherapy—clinical impact of treatment time-of-day: a systematic review
Dorela D. Shuboni-Mulligan, Ghislain Breton, DeeDee Smart, Mark Gilbert, Terri S. Armstrong
Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function
Hillary G. Caruso, Ryuma Tanaka, Jiyong Liang, Xiaoyang Ling, Aria Sabbagh, Verlene K. Henry, Tiara L. Collier, Amy B. Heimberger
Increased 14C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with 11C-acetate PET imaging
Sho Koyasu, Yoichi Shimizu, Akiyo Morinibu, Tsuneo Saga, Yuji Nakamoto, Kaori Togashi, Hiroshi Harada
Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma
Anne Guyot, Mathilde Duchesne, Sandrine Robert, Anne-Sophie Lia, Paco Derouault, Erwan Scaon, Leslie Lemnos, Henri Salle, Karine Durand, François Labrousse
White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab
Fayez Estephan, Xiaobu Ye, Omar Dzaye, Nina Wagner-Johnston, Lode Swinnen, Douglas E. Gladstone, Rich Ambinder, David Olayinka Kamson, Sebastian Lambrecht, Stuart A. Grossman, Doris D. M. Lin, Matthias Holdhoff
Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab
Fayez Estephan, Xiaobu Ye, Omar Dzaye, Nina Wagner-Johnston, Lode Swinnen, Douglas E. Gladstone, Rich Ambinder, David Olayinka Kamson, Sebastian Lambrecht, Stuart A. Grossman, Doris D. M. Lin, Matthias Holdhoff
Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome
Annamaria Biczok, Christine Jungk, Rupert Egensperger, Andreas von Deimling, Bogdana Suchorska, Joerg C. Tonn, Christel Herold-Mende, Christian Schichor
Association between extent of resection on survival in adult brainstem high-grade glioma patients
Joshua Doyle, Adham M. Khalafallah, Wuyang Yang, Yi Sun, Chetan Bettegowda, Debraj Mukherjee
Complementary and alternative medicine use in glioma patients in France
Emilie Le Rhun, Patrick Devos, Véronique Bourg, Amélie Darlix, Véronique Lorgis, Guido Ahle, Mathieu Boone, Luc Taillandier, Elsa Curtit, Louis Gras, Christine Lebrun Frenay, Dorothee Gramatzki, Carole Ramirez, Nicolas Simon, Michael Weller
Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification
Elena Jansen, Christina Hamisch, Daniel Ruess, Dieter Henrik Heiland, Roland Goldbrunner, Maximilian I. Ruge, Oliver Schnell, Stefan J. Grau
Analysis of intra-operative variables as predictors of 30-day readmission in patients undergoing glioma surgery at a single center
Iahn Cajigas, Anil K. Mahavadi, Ashish H. Shah, Veronica Borowy, Nathalie Abitbol, Michael E. Ivan, Ricardo J. Komotar, Richard H. Epstein
Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis
Steven S. Carey, Zsila Sadighi, Shengjie Wu, Jason Chiang, Giles W. Robinson, Yahya Ghazwani, Anthony P. Y. Liu, Sahaja Acharya, Thomas E. Merchant, Frederick A. Boop, Amar Gajjar, Ibrahim Qaddoumi
Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients
Wolfgang Wick, Andriy Krendyukov, Klaus Junge, Thomas Höger, Harald Fricke
Mortality patterns in long-term survivors of childhood or adolescent central nervous system tumour in Sweden
Wuqing Huang, Jan Sundquist, Kristina Sundquist, Jianguang Ji
Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases
Christian Iorio-Morin, Rosalie Mercure-Cyr, Gabrielle Figueiredo, Charles Jean Touchette, Laurence Masson-Côté, David Mathieu
Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live‑video randomized control trial
Jonathan Greenberg, Sarah Carter, Ethan Lester, Christopher J. Funes, Eric A. Macklin, Scott Plotkin, Ana-Maria Vranceanu
Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery
Seung Won Choi, Kyung Rae Cho, Jung Won Choi, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Jung-Il Lee
Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases
Amelia Jardim, Justin Scott, Zachery Drew, Matthew C. Foote, Ananthababu P. Sadasivan, Bruce Hall, Sarah L. Olson, Mihir Shanker, Mark B. Pinkham
EGFR gene amplification in monocentric and multicentric glioblastoma
Lucia Nichelli, Didier Dormont, Marc Sanson, Anna Luisa Di Stefano
Diagnostic delay in children with central nervous system tumors and the need to improve education
Ibrahim Qaddoumi, Thomas E. Merchant, Fredrick A. Boop, Amar Gajjar
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016
Roberta Rudà, Alessia Pellerino, Andrea Pace, Carmine Maria Carapella, Cristina Dealis, Manuela Caroli, Marina Faedi, Lorenzo Bello, Enrica Migliore, Giulia Marchese, Luca Bertero, Paola Cassoni, Riccardo Soffietti
Correction to: Efficacy of Dabrafenib for three children with brainstem BRAFV600E positive ganglioglioma
Philippe Laflamme, Maria Kondyli, Tariq Aljared, Sofia Miconiatis, Christine Saint-Martin, Jean-Pierre Farmer, Roy W. Dudley, Sébastien Perreault, Nada Jabado, Valérie Larouche